Quotient Limited to Participate in the Morgan Stanley 15th Annual Global Healthcare Conference

JERSEY, Channel Islands, Aug. 30, 2017 -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company’s Chairman and Chief Executive Officer, Paul Cowan, will present at the Morgan Stanley 15^th Annual Global Healthcare Conference on Wednesday, September 13, 2017 at 1:35 pm Eastern Time at the Grand Hyatt New York in New York, NY. The Company’s Chief Financial Officer, Chris Lindop, will also be participating in the conference.

About Quotient Limited

Quotient is a commercial-stage diagnostics company committed to reducing healthcare costs and improving patient care through the provision of innovative tests within established markets. With an initial focus on blood grouping and serological disease screening, Quotient is developing its proprietary MosaiQ™ technology platform to offer a breadth of tests that is unmatched by existing commercially available transfusion diagnostic instrument platforms. The company's operations are based in Edinburgh, Scotland; Eysins, Switzerland and Newtown, Pennsylvania.

The Quotient logo and MosaiQ™ are registered trademarks or trademarks of Quotient Limited and its subsidiaries in various jurisdictions.

CONTACT: 
Christopher Lindop, Chief Financial Officer — [email protected]; +41 (0)799 61 69 38